about
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsThe X-factor in primary biliary cirrhosis: monosomy X and xenobioticsGenome-wide meta-analyses identify three loci associated with primary biliary cirrhosisModulation of CD4⁺ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis.Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.Human β-Defensin 2 in Primary Sclerosing Cholangitis.Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosisShotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cellsRole of cholangiocytes in primary biliary cirrhosis.Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature.Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growthImmunopathogenesis of primary biliary cirrhosis: an old wives' tale.Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis.Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment.DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosisInternational genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.Advances in pharmacotherapy for primary biliary cirrhosis.Towards common denominators in primary biliary cirrhosis: the role of IL-12Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary CholangitisIs autoimmunity a matter of sex?Innate immunity and primary biliary cirrhosis.Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisGeoepidemiology, gender and autoimmune disease.The limitations and hidden gems of the epidemiology of primary biliary cirrhosis.Genetics and epigenetics of primary biliary cirrhosis.Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver DiseasesMaking Sense of Autoantibodies in Cholestatic Liver Diseases.Geoepidemiology, Genetic and Environmental Risk Factors for PBC.The epigenetics of PBC: The link between genetic susceptibility and environment.Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.Hepatitis C virus eradication with direct antiviral agents and liver cancer recurrence: Is the best the enemy of the good?Primary biliary cholangitis: a comprehensive overview.X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma.Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.Y chromosome loss in male patients with primary biliary cirrhosis.Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis.The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis.Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
P50
Q24617796-BA04FBBB-E62B-434F-A6BB-0A9A971E1162Q26830032-F83C2603-DE98-4EE3-B67E-A006119A6C7DQ28943317-82798DDE-91E2-4D0F-B8C4-0B0E19CB9B68Q33395512-A3868FE1-D014-4648-B0D6-FD58C3705B75Q33419647-A3A139DF-922A-42C6-904C-C6A3F1DA823EQ33551867-76B469D3-47D2-445D-829F-48638824E3B9Q33579196-C0B8D21E-E5C6-4A6A-B7CC-E64F282437A6Q34243335-E4582C8C-E1EC-4E21-99F6-B0ACA0891509Q34276575-4A4ED367-E7E3-473A-838C-FCA232EAD384Q34346124-6058ED82-77B7-4A79-921A-B88B50B6DD21Q35321923-E8EC54BF-BF6E-4EBF-A8A6-BCE7B4B32880Q35614763-ACD41260-AAC8-47DD-BB03-B906BFF12C09Q35631675-EB2AFBCA-7E5F-4BBF-BB57-AA8C4A708AD4Q35687041-FEB811BA-4951-4F70-929F-B1A6AF61E916Q35819281-82290B4F-A4E9-4027-8A5B-C49A64039F94Q36087896-9AD9BD34-80D3-4063-8B46-7E83C2FDF35CQ36116022-E966D1B1-04DA-4D7D-8E93-A0C93C382A31Q36632355-9070BBC6-1C4C-4BE9-8556-BDF31F17AB5EQ36914749-54A5F37B-8285-4B0A-A98D-6CCC3D6204D0Q37207818-3F1C4D47-3FEB-4566-89AD-F34AE177FA93Q37387453-F6DDB20C-D97A-42FA-8908-060B1D98318BQ37683538-B247A72D-4A80-4C3A-8F7B-2A470965862FQ37964811-F096C3F6-2662-44E7-AD5C-B857758DB57CQ38122898-A82757B6-41B5-4B7E-A9DF-218CA4EF694AQ38233434-38DC0F67-4881-4368-BBC8-7FE33389D6FBQ38413146-3D42E5EE-0AF9-47C1-88DD-505227F1C0A9Q38543052-3E258360-9BC8-4002-8B2A-DECECBF5B7EBQ38642911-CBB361EB-3C24-43EB-84C5-2104F238370BQ38660815-86EEFBE3-12D3-47B0-8BA5-CD7CFB7AB3B1Q38876166-92F2E4C0-3BB8-44D6-B038-0D703F234F6EQ42155343-94AF47AB-13EE-47C7-89CC-680A9DE5C955Q43471968-337E0E50-CA1C-4F38-9DCD-3E9DA0E34301Q45327946-12BC1946-7B54-4DF7-9245-358A744456A7Q46078221-7871EA67-AD6F-4D6B-8B46-A703230518C0Q46096164-E6A533C4-8D1F-44A6-8E17-3D792A5AB7C3Q46194973-1FE95B56-7061-4ADE-A194-52807F28A2A6Q51276214-AE3F7F93-F332-4561-90E6-CFD522DDB89EQ51373148-BEAEB2D6-B220-46FC-A1D6-38A9AEAB22A2Q53592068-D77F4C65-CCC2-4AB1-9253-50F04D97313FQ54384963-0EA50852-50EF-470B-B43D-7E9A2A322B4C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
A Lleo
@ast
A Lleo
@en
A Lleo
@es
A Lleo
@nl
type
label
A Lleo
@ast
A Lleo
@en
A Lleo
@es
A Lleo
@nl
prefLabel
A Lleo
@ast
A Lleo
@en
A Lleo
@es
A Lleo
@nl
P108
P106
P1153
13610386800
P31
P496
0000-0002-0561-7902